Rekombinanter DNA-RNA Hybrid Antikörper
Kurzübersicht für Rekombinanter DNA-RNA Hybrid Antikörper (ABIN7572906)
Target
Antikörpertyp
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Expressionssystem
- Mammalian cells
-
Verwendungszweck
- Recombinant Anti-DNA-RNA Hybrid Antibody(S9.6)
-
Aufreinigung
- Protein A or G purified from cell culture supernatant.
-
Reinheit
- >95 %
-
Isotyp
- IgG2a, kappa
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.58 mg/mL
-
Buffer
- 0.01M PBS, pH 7.4.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at +4°C short term (1-2 weeks). Store at -20 °C 12 months. Store at -80°C long term.
-
-
-
: "Endonuclear Circ-calm4 regulates ferroptosis via a circR-Loop of the COMP gene in pulmonary artery smooth muscle cells." in: European journal of pharmacology, Vol. 982, pp. 176944, (2024) (PubMed).
: "Amplification-Free Analysis of Bladder Cancer MicroRNAs on Wrinkled Silica Nanoparticles with DNA-Functionalized Quantum Dots." in: Analytical chemistry, Vol. 96, Issue 12, pp. 4860-4867, (2024) (PubMed).
-
-
- DNA-RNA Hybrid
-
Hintergrund
- DNA-RNA Hybrid
Target
-